In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Wearables in Virtual Trials
Marie McCarthy shares her insights on how wearables are improving the clinical trial experience for patients and satisfying the need to collect data for real-world use studies, "Connected devices drastically improve trials' patient-centricity, generating endpoints perceived as more valuable having greater value."
-
Immunotherapy Combination Trials Q&A
Q&A article published by Pharmaceutical Market Europe (PME) featuring Chris Learn and Martin Lachs, discussing how best to achieve success in an increasingly crowded and competitive immuno-oncology field, where the rapid evolution of trial design has occurred as a competitive necessity.
-
ICON Introduces New Drug Safety Reporting Solution
An Outsourcing Pharma article featuring commentary from Quintin Van Wyk on ICON’s new drug safety reporting platform. Launched at DIA Europe, the platform automates complex processes to ensure compliance in an ever-changing regulatory space.
-
Adopting a Strategy to Identify Highest Commercial Value Products
A thought leadership article written by Vicki Anastasi, published by the Journal of Medical Device Regulation (JMDR), exploring the challenges of transitioning to the new EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) and advising manufactures on how to prioritise their product portfolio to ensure a smooth transition.
-
A Primer for Manufacturers Adjusting to Value-Based Healthcare
A thought leadership article published by MPO Magazine, written by ICON expert Vicki Anastasi, on the challenges of a value-based healthcare market and the importance of demonstrating clinical efficacy and cost impact of new devices. The piece discusses how partnering with an experienced CRO with a track record in clinical evidence generation, economic modelling, and commercialisation can help devices to achieve strong market impact.
-
ICON Rolls Out Digital Platform Developed with Dimension Data
An article published by Fierce Biotech on ICON’s new digital platform developed with Dimension Data. The innovative platform supports digital trials and patient interaction by reducing complexity and cost to ultimately enhance the efficiency and productivity of client pipelines.
-
Improving Pharma R&D Efficiency
With development cycles becoming too long, trial complexity increasing, and greater scrutiny of the economic value of new treatments, pharma R&D business models are under significant pressures to improve R&D efficiency. In an ICON industry survey of pharmaceutical executives and professionals on Pharma R&D Efficiency, the challenges most frequently cited are explored. Learn more in this Applied Clinical Trials Industry Trends 2019 article.
-
Parkinson’s Disease Clinical Trials
An Outsourcing-Pharma (OSP) article exploring Parkinson’s disease clinical trials, featuring commentary from ICON Central Nervous System (CNS) experts Dr Peter Schueler (Sr VP, Drug Development Services) and Haichen Yang (VP, Global Therapeutic Lead). For neurological research areas, digital endpoints may soon be used as primary endpoints, allowing for in-home trials to be conducted over longer periods of time.
-
ICON Issues Financial Guidance for Full Year 2019
ICON announced its financial guidance for the year ended December 31, 2019, featuring commentary from Steve Cutler
-
Centre of the pharmaverse
Patients’ role in their own health has evolved more in the past decade than in the previous six combined. Consequently, an all-encompassing digital era has opened unique opportunities for industry to engage with patients meaningfully, while also creating a modernised healthcare landscape which yields trust and cooperation. Read more in PharmaTimes' January 2019 article, Centre of the pharmaverse, featuring insights from ICON experts Kelly Franchetti and Caroline Forkin.
